These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26206991)

  • 41. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.
    Ingelman-Sundberg M; Sim SC; Gomez A; Rodriguez-Antona C
    Pharmacol Ther; 2007 Dec; 116(3):496-526. PubMed ID: 18001838
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical application of antidepressant pharmacogenetics: Considerations for the design of future studies.
    Fabbri C; Serretti A
    Neurosci Lett; 2020 May; 726():133651. PubMed ID: 29906483
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes.
    Altar CA; Carhart JM; Allen JD; Hall-Flavin DK; Dechairo BM; Winner JG
    Pharmacogenomics J; 2015 Oct; 15(5):443-51. PubMed ID: 25686762
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacogenetics of ecstasy: CYP1A2, CYP2C19, and CYP2B6 polymorphisms moderate pharmacokinetics of MDMA in healthy subjects.
    Vizeli P; Schmid Y; Prestin K; Meyer Zu Schwabedissen HE; Liechti ME
    Eur Neuropsychopharmacol; 2017 Mar; 27(3):232-238. PubMed ID: 28117133
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacogenetics of antidepressant drugs: current clinical practice and future directions.
    Narasimhan S; Lohoff FW
    Pharmacogenomics; 2012 Mar; 13(4):441-64. PubMed ID: 22380000
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical relevance of a pharmacogenetic approach using multiple candidate genes to predict response and resistance to imatinib therapy in chronic myeloid leukemia.
    Kim DH; Sriharsha L; Xu W; Kamel-Reid S; Liu X; Siminovitch K; Messner HA; Lipton JH
    Clin Cancer Res; 2009 Jul; 15(14):4750-8. PubMed ID: 19584153
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of genetic polymorphisms related to neurotransmitters and cytochrome P-450 enzymes in response to antidepressants.
    Lee MS
    Drugs Today (Barc); 2007 Aug; 43(8):569-81. PubMed ID: 17925888
    [TBL] [Abstract][Full Text] [Related]  

  • 48. From pharmacogenetics to imaging pharmacogenetics: elucidating mechanisms of antidepressant response.
    Brandl EJ; Walter H
    Pharmacogenomics; 2017 Jul; 18(10):927-930. PubMed ID: 28639501
    [No Abstract]   [Full Text] [Related]  

  • 49. Personalized medicine in psychiatry: new technologies and approaches.
    Costa e Silva JA
    Metabolism; 2013 Jan; 62 Suppl 1():S40-4. PubMed ID: 23018148
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacogenetics of drug metabolising enzymes: importance for personalised medicine.
    Oscarson M
    Clin Chem Lab Med; 2003 Apr; 41(4):573-80. PubMed ID: 12747605
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacogenetics approach to therapeutics.
    Koo SH; Lee EJ
    Clin Exp Pharmacol Physiol; 2006; 33(5-6):525-32. PubMed ID: 16700889
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment.
    Crettol S; Déglon JJ; Besson J; Croquette-Krokar M; Hämmig R; Gothuey I; Monnat M; Eap CB
    Clin Pharmacol Ther; 2006 Dec; 80(6):668-81. PubMed ID: 17178267
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacogenetics and interactions of antidepressants in the treatment of co-morbid illness.
    Mihaljević-Peles A; Sagud M; Bozina N; Zivković M; Jovanović N
    Psychiatr Danub; 2009 Sep; 21(3):399-400. PubMed ID: 19794364
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Polymorphism of ABCB1 and ABCG2 genes encoding drug transporters and their investigation by pyrosequencing].
    Dribnokhodova OP; Mironov KO; Dunaeva EA; Shipulin GA
    Eksp Klin Farmakol; 2012; 75(10):29-36. PubMed ID: 23240156
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects.
    Sim SC; Kacevska M; Ingelman-Sundberg M
    Pharmacogenomics J; 2013 Feb; 13(1):1-11. PubMed ID: 23089672
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of pharmacogenomic testing in psychiatry: Real world examples.
    Dinama O; Warren AM; Kulkarni J
    Aust N Z J Psychiatry; 2014 Aug; 48(8):778. PubMed ID: 24413808
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical validity of cytochrome P450 metabolism and serotonin gene variants in psychiatric pharmacotherapy.
    Altar CA; Hornberger J; Shewade A; Cruz V; Garrison J; Mrazek D
    Int Rev Psychiatry; 2013 Oct; 25(5):509-33. PubMed ID: 24151799
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pharmacogenetic challenges in the treatment of mental diseases].
    Sukhanov VA; Piruzian LA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(8):83-6. PubMed ID: 15554149
    [No Abstract]   [Full Text] [Related]  

  • 60. [Prescription of antidepressants in the treatment of pain: role of pharmacogenetics].
    Rodieux F; Piguet V; Berney P; Desmeules J; Besson M
    Rev Med Suisse; 2015 Jun; 11(480):1374-9. PubMed ID: 26267942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.